![](https://distributor.devicare.com/wp-content/uploads/2019/05/EUParlamient_web.jpg)
![](https://distributor.devicare.com/wp-content/uploads/2019/05/EUParlamient_web.jpg)
The European Parliament voted to mobilise almost €700 billion in investments to boost competitiveness and growth by supporting IP-intensive enterprises through InvestEU programme, on January 16. The InvestEU, which is part of the EU’s Multi-Annual Financial (MFF) Framework 2021-2027, brings together the various instruments to expand the Juncker Plan model.
IP Europe Alliance, which Devicare is member, is one of the stakeholders that contributed to this successfuly news.
“This is an outstanding achievement” says Rosendo Garganta, CEO of Devicare. “R&D is the foundation for many SMEs such as ours. We know that whether SMEs have support in IP protection and portfolio development or not, can be the difference between succeeding and failing. This is why we are so positive about the European Parliament’s decision” remarks Garganta.
IP Europe is a coalition of IP and R&D intensive organizations headquartered in Europe. Its goal is to educate European policy-makers and give a voice to innovative companies, including SMEs, that rely on their R&D investments and their patents to succeed.